Navigation Links
Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
Date:5/23/2013

NEW YORK, May 23, 2013 /PRNewswire/ -- Echo Pharma Acquisition Limited ("Royalty Pharma") announced today that it has committed to waive down the Acceptance Threshold from 90 percent to 50 percent of Maximum Elan Shares Affected plus one Elan Share in accordance with the terms of the Revised Offer Document issued today, subject to the conditions summarized below.

Under the terms of the Increased Offer, Royalty Pharma is offering to acquire Elan (NYSE: ELN) for $12.50 per share in cash. The Increased Offer represents a compelling value of $4.6 billion for Elan's Tysabri Royalty, a 42 percent premium to the $3.25 billion at which Elan sold approximately half of its interest in Tysabri to Biogen. The Increased Offer also represents a premium of 45 percent to the Undisturbed Elan Enterprise Value.

In a letter sent to Elan Stockholders today, Royalty Pharma outlined and reiterated the key points of its Increased Offer:

  • The Increased Offer of $12.50 per Elan Share in cash is fully financed and is not conditional on due diligence;
  • The Increased Offer is conditional on Elan Stockholders voting against the Theravance Transaction and all transactions announced by Elan on May 20, 2013 that are put to a shareholder vote; and
  • Royalty Pharma has committed to waive the Acceptance Threshold from 90 percent to 50 percent of Maximum Shares Affected plus one Elan Share in accordance with the Revised Offer Document.

"The Elan directors have failed to maintain an appropriate balance between supporting management's acquisition plan and their fiduciary responsibilities to Elan shareholders in respect of Royalty Pharma's offer," said Pablo Legorreta , Founder and Chief Executive Officer of Royalty Pharma. "We believe that the increased offer provi
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Royalty Rates Take Center Stage in Biopharma Dealmaking
2. Royalty Pharma Announces Proposal To Acquire Elan
3. PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
4. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
5. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
6. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
7. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
8. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
9. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
10. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
11. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/hmlfbq/investment ) ... Analysis of the US Medical Device Sector " ... http://photos.prnewswire.com/prnh/20130307/600769 This analysis ... identifies the key trends and rationale for undertaking ... and acquisitions. The study will be ...
(Date:12/22/2014)... Cyberonics, Inc. (NASDAQ: CYBX ), a global leader ... today announced it will participate in the 33 rd ... in San Francisco . ... speak at 11:00 AM Pacific Time.  A live audio webcast ... Investor Relations link on the Cyberonics home page at ...
(Date:12/22/2014)... , Dec. 22, 2014 /PRNewswire/ -- RXi Pharmaceuticals ... company focused on discovering, developing and commercializing innovative ... technologies, today issued the following open letter to ... , Dr. Med. Sc. Dear RXi ... a number of inaccurate statements posted on certain ...
Breaking Medicine Technology:Investment Analysis of the US Medical Device Sector 2RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6
(Date:12/25/2014)... 2014 Thousands of transvaginal mesh lawsuits ... a number of multidistrict litigations currently underway in U.S. ... LLP reports. According to an Order issued on December ... Joint Status Conference in all of the proceedings on ... directed to submit a proposed agenda to the Court ...
(Date:12/25/2014)... 2014 Plugin creators from Pixel Film ... fully customizable business presentation tool made specifically for ... 5k business tool, users can now display their stats ... Pixel Film Studios. “ProFire 5k gives users a multiple ... professionalism to a presentation” , Pixel Film Studios takes ...
(Date:12/25/2014)... Each year trauma accounts for approximately 42 ... across the nation (according to the Centers for ... Hospital Ambulatory Medical Care Survey collected data from ... They estimated that there were between 3.5 and 4.4 ... diagnosis of broken bone or fracture. , When ...
(Date:12/24/2014)... AlignLife of Wauwatosa loves helping those ... During the holiday season, AlignLife looks forward to their annual ... Dr. Sara Mahalko-Leonhardt, owner of AlignLife. "It brings our patients ... we are able to give kids toys for Christmas who ... the generosity of our patients." , The 70 toys were ...
(Date:12/24/2014)... 2014 Epigenetics finds applications in a ... oncology, drug discovery, developmental biology, and research for metabolic ... of the most widely used techniques for the discovery ... prevalence of cancer is rapidly growing worldwide. In 2012, ... cancer deaths, and 32.6 million people living with cancer ...
Breaking Medicine News(10 mins):Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 3Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 4Health News:AlignLife of Wauwatosa Brings Joy to Less Fortunate Families 2Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 2Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 3
... Reporter , WEDNESDAY, Jan. 12 (HealthDay News) -- The next time ... What really matters, new research suggests, is whether your language ... you ask? Well, it,s kind of like chemistry -- it,s there ... focused on was the use of such words as personal pronouns ...
... to traumatic situations demonstrate a more persistent memory of ... with an aversive stimulus - and lack the ability ... that of people who suffer from Post-Traumatic Stress Disorder ... to highly traumatic situations, such as a violent attack, ...
... are fairly common disorders that affect a large proportion ... Clinical Neurophysiology at the Center for Healthy Ageing at ... is head of the Danish Centre for Sleep Medicine, ... country. "Previous studies show that these disorders ...
... worm acts as a ,disguise, for the parasite, resulting in ... The bacteria protect the worm from the body,s natural ... immune system responds appropriately, releasing cells, called eosinophils, that kill ... parasite, but the long treatment regime means that it has ...
... WEDNESDAY, Jan. 12 (HealthDay News) -- Even though they can,t ... spoken words and use the same brain structures as adults ... findings challenge the widely held belief that infants might use ... that this ability begins primitively and evolves into the process ...
... JACKSONVILLE, Fla. A study by researchers at Mayo Clinic,s ... a new twist to the body of evidence suggesting human ... hormone receptors in laboratory mice, neuroscientists identified a new molecular player ... the Jan. 11 online issue of PLoS Biology ...
Cached Medicine News:Health News:Matching Language, True Love? 2Health News:Matching Language, True Love? 3Health News:Drug reduces the increase in fear caused by previous traumatic experiences in mice 2Health News:Sleep-disordered breathing comes at a heavy cost 2Health News:Study sheds new light on river blindness parasite 2Health News:Infants Process Words Much Like Adults, Study Finds 2Health News:Feast or famine: Researchers identify leptin receptor's sidekick as a target for appetite regulation 2
... million people are diagnosed with varicose veins ... patients never seek treament and are apprehensive ... offer them an effective alternative to conventional ... or hook phlebectomy), is considered a laborious ...
...
Inquire...
... in a Compact Size , Featuring design ... along with Alokas latest proprietary electronic technologies, ... portable units suffer from hardware and software ... sets new standards for whats possible in ...
Medicine Products: